The landscape of dementia prognosis has advanced considerably with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based tests that could detect Alzheimer's pathology a long time just before signs and symptoms arise. Although these technological advances characterize exceptional development in comprehension neurodegenerative illn... https://francesn653rdm3.bloggosite.com/profile